Company intelligence / Profile preview

ICON Investments

Dublin, Ireland

Ownership: Private
Employees: ~41900
Development stage: Other

Overview

ICON plc is a global contract research organization (CRO) providing outsourced clinical research, development, and commercial services to pharmaceutical, biotechnology, medical device, and government/public health organizations. The company supports over 500 biotech sponsors annually and is recognized for its large biotech-focused division and global reach, with tailored teams to accelerate drug development and delivery of evidence-based results to investors, partners, and regulatory authorities[1][2].

Industry: Contract Research Organization

Beyond the preview

Go deeper on ICON Investments.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ICON Investments.

Explore the full profile